Use of Calretinin, CD56, and CD34 for Differential Diagnosis of Schwannoma and Neurofibroma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: It is important to differentiate between schwannomas and neurofibromas for the cases in which the histopathologic features overlap. Depending on the tumor type, surgeons can decide on a treatment method and whether to preserve or sacrifice the nerve; the possibility of malignant transformation in the case of neurofibromas also needs to be considered. Methods: We studied 101 cases of schwannoma and 103 cases of neurofibroma. All the hematoxylin and eosin slides for these cases were reviewed, and tissue microarrays were prepared from the representative areas. Immunohistochemical analysis was performed using antibodies for S-100 protein, calretinin, CD56 and CD34. Results: All the tumors except 3 neurofibromas were positive for the S-100 protein. Calretinin was found in 26.7% of the schwannomas (27/101), but it was not found in any of the neurofibromas. CD56 was positive in 77.2% of the schwannomas (78/101) and in 9.8% of the neurofibromas (10/102). CD34 was positive in 42.5% of the schwannomas (43/101) and in 80.2% of the neurofibromas (81/101). Statistically, calretinin was significantly specific for schwannomas (p<0.001) and CD56 was also sensitive for these tumors (p<0.001). On the other hand, a CD34 expression seemed highly sensitive (p<0.001) for neurofibromas. Conclusions: We concluded that combined immunohistochemical analysis for calretinin, CD56, and CD34 may be very useful for differentiating schwannomas from neurofibromas.
Abstract
Background: It is important to differentiate between schwannomas and neurofibromas for the cases in which the histopathologic features overlap. Depending on the tumor type, surgeons can decide on a treatment method and whether to preserve or sacrifice the nerve; the possibility of malignant transformation in the case of neurofibromas also needs to be considered. Methods: We studied 101 cases of schwannoma and 103 cases of neurofibroma. All the hematoxylin and eosin slides for these cases were reviewed, and tissue microarrays were prepared from the representative areas. Immunohistochemical analysis was performed using antibodies for S-100 protein, calretinin, CD56 and CD34. Results: All the tumors except 3 neurofibromas were positive for the S-100 protein. Calretinin was found in 26.7% of the schwannomas (27/101), but it was not found in any of the neurofibromas. CD56 was positive in 77.2% of the schwannomas (78/101) and in 9.8% of the neurofibromas (10/102). CD34 was positive in 42.5% of the schwannomas (43/101) and in 80.2% of the neurofibromas (81/101). Statistically, calretinin was significantly specific for schwannomas (p<0.001) and CD56 was also sensitive for these tumors (p<0.001). On the other hand, a CD34 expression seemed highly sensitive (p<0.001) for neurofibromas. Conclusions: We concluded that combined immunohistochemical analysis for calretinin, CD56, and CD34 may be very useful for differentiating schwannomas from neurofibromas.
참고문헌 (20)
- Fine SW, "Immunohistochemical staining for calretinin is useful for differentiating schwannomas from neurofibromas", Am J Clin Pathol, 122, pp.552~559 (2004)
- Skovronsky DM, "Pathologic classification of peripheral nerve tumors", Neurosurg Clin N Am, 15, pp.157~166 (2004)
- Nascimento AF, "The controversial nosology of benign nerve sheath tumors: neurofilament protein staining demonstrates intratumoral axons in many sporadic schwannomas", Am J Surg Pathol, 31, pp.1363~1370 (2007)
- Tsai WC, "Differentiation between schwannomas and neurofibromas in the extremities and superficial body: the role of high-resolution and color Doppler ultrasonography", J Ultrasound Med, 27, pp.161~166 (2008)
- Dabbs DJ, "Diagnostic immunohistochemistry", pp.75~77 (2002), Churchill Livingstone
- Dabbs DJ, "Diagnostic immunohistochemistry", pp.80~ (2002), Churchill Livingstone
- Miettinen MM, "Diagnostic soft tissue pathology", pp.53~57 (2003), Churchill Livingstone
- Miettinen MM, "Diagnostic soft tissue pathology", pp.347~360 (2003), Churchill Livingstone
- Weiss SW, "Enzinger and Weiss’s soft tissue tumors", pp.135~ (2008), Mosby
- Hirose T, "Immunohistochemical demonstration of EMA", Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors, 2003, pp.16, 293~298
- Rosai J, "Rosai and Ackerman’s surgical pathology. 9th ed", pp.2264~2269 (2004), Mosby
- Weiss SW, "Enzinger and Weiss’s soft tissue tumors", pp.835~872 (2008), Mosby
- Martinoli C, "Tendon and nerve sonography", Radiol Clin North Am, 37, pp.691~711 (1999)
- Spinner RJ, "Colocalized cellular schwannoma and plexiform neurofibroma in the absence of neurofibromatosis: case report", J Neurosurg, 107, pp.435~439 (2007)
- Laskin WB, "Benign epithelioid peripheral nerve sheath tumors of the soft tissues: clinicopathologic spectrum of 33 cases", Am J Surg Pathol, 29, pp.39~51 (2005)
- Weiss SW, "Enzinger and Weiss’s soft tissue tumors", pp.153~ (2008), Mosby
- Dabbs DJ, "Diagnostic immunohistochemistry", pp.209~210 (2002), Churchill Livingstone
- Dabbs DJ, "Diagnostic immunohistochemistry", pp.142~143 (2002), Churchill Livingstone
- Miettinen MM, "Diagnostic soft tissue pathology", pp.45~46 (2003), Churchill Livingstone
- Weiss SW, "Enzinger and Weiss’s soft tissue tumors", pp.143~147 (2008), Mosby